Skip to main content
Top

Clinical and Translational Oncology

Issue 8/2007

Content (11 Articles)

Editorial

PET-CT in oncology

A. Hervás Morón

News and Views

The story of a fly

E. García Jordá

Educational Series

Molecular biology of neuroblastoma

V. Castel, E. Grau, R. Noguera, F. Martínez

Educational Series

mTOR signaling in human cancer

J. Albanell, A. Dalmases, A. Rovira, F. Rojo

Educational Series

PET-CT in clinical oncology

A. Maldonado, F. J. González-Alenda, M. Alonso, J. M. Sierra

Reviews

Toxicity associated to radiotherapy treatment in lung cancer patients

M. López Rodríguez, L. Cerezo Padellano

Reviews

Axillary surgery in breast cancer patients

A. Millet, C. A. Fuster, A. Lluch, F. Dirbas

Research Articles

Trans-platinum(II) complexes with cyclohexylamine as expectator ligand induce necrosis in tumour cells by inhibiting DNA synthesis and RNA transcription

V. Cepero, B. García-Serrelde, V. Moneo, F. Blanco, A. M. González-Vadillo, A. Álvarez-Valdés, C. Navarro-Ranninger, A. Carnero

Case Reports

Pathological femur fracture secondary to radiation therapy for soft tissue sarcoma

C. Conill, X. Tomás, A. Combalia-Aleu, A. Palacín, I. Planas, J. Maurel

Case Reports

Heart metastases and superior vena cava syndrome

A. S. Rubiales, A. Reyes, A. F. Renedo, J. C. Torrego, J. Puertas, G. Marcos

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine